Stock 300573 SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shenyang Xingqi Pharmaceutical Co.,Ltd.

Equities

300573

CNE100002DV1

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
259.6 CNY +0.55% Intraday chart for Shenyang Xingqi Pharmaceutical Co.,Ltd. +19.62% +42.38%
04-26 Shenyang Xingqi Pharmaceutical's Q1 Profit Jumps 80% MT
04-25 Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

SHENYANG XINGQI PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of ophthalmic drugs. The Company’s main products are ophthalmic prescription drugs, including corneal repairing drugs, anti-bacteria drugs, artificial tears, anti-inflammation drugs, anti-allergic drugs, as well as anti-hyperemia & fatigue relief drugs and others. The Company mainly distributes its products within domestic market.

Number of employees: 1,995

Sales per Business

CNY in Million2022Weight2023Weight Delta
Eye Drops
45.2 %
448 35.9 % 663 45.2 % +47.86%
Gel/Eye Ointment
25.5 %
316 25.3 % 374 25.5 % +18.37%
Medical Care
23.9 %
406 32.5 % 351 23.9 % -13.49%
Solution
3.5 %
57 4.6 % 52 3.5 % -8.89%
Other
1.9 %
23 1.9 % 28 1.9 % +21.43%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
1,250 100.0 % 1,468 100.0 % +17.42%

Managers

Managers TitleAgeSince
E Gao CEO
 Chief Executive Officer 50 00-07-04
Xiao Yu Qu
37 -
Ya Nan Cheng DFI
 Director of Finance/CFO 50 02-12-31
Ji Dong Liu CHM
 Chairman 67 00-07-04
Chun Hua Li ADM
 Chief Administrative Officer 47 07-12-31
Qiang Yang CTO
 Chief Tech/Sci/R&D Officer 40 11-12-31
Shao Yao Zhang BRD
 Director/Board Member 54 98-12-31
Shuo Wang IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Xiao Yan Kong BRD
 Director/Board Member 51 01-04
Ji Dong Liu CHM
 Chairman 67 00-07-04
E Gao CEO
 Chief Executive Officer 50 00-07-04
Shao Yao Zhang BRD
 Director/Board Member 54 98-12-31
Ya Nan Cheng DFI
 Director of Finance/CFO 50 02-12-31
Qiang Yang CTO
 Chief Tech/Sci/R&D Officer 40 11-12-31
Chun Hua Li ADM
 Chief Administrative Officer 47 07-12-31
Xiao Bin Dai BRD
 Director/Board Member 67 21-01-13
Xiao Yu Qu CHM
 Chairman 37 13-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 124,589,194 82,183,296 ( 65.96 %) 0 65.96 %

Shareholders

NameEquities%Valuation
Fullgoal Fund Management Co., Ltd.
12.58 %
11,979,607 12.58 % 355 M ¥
Ji Dong Liu
9.303 %
8,860,425 9.303 % 262 M ¥
Basic Pension Insurance Fund 16022 Portfolio
3.161 %
3,010,822 3.161 % 89 M ¥
Basic Pension Insurance Fund 16021 Portfolio
3.094 %
2,946,355 3.094 % 87 M ¥
Citic Securities Co., Ltd. (Invt Port)
2.587 %
2,463,546 2.587 % 73 M ¥
Tanzhen Investment Management Partnership Enterprise LP
1.616 %
1,539,172 1.616 % 46 M ¥
Zhong Ou Asset Management Co., Ltd
0.8808 %
838,914 0.8808 % 25 M ¥
Franklin Templeton Sealand Fund Management Co., Ltd.
0.6302 %
600,212 0.6302 % 18 M ¥
Huatai Baoxing Fund Management Co. Ltd.
0.4829 %
459,911 0.4829 % 14 M ¥
RBC Global Asset Management (Asia) Ltd.
0.4801 %
457,269 0.4801 % 14 M ¥
NameEquities%Valuation
Ji Dong Liu
92.50 %
26,581,275 92.50 % 787 M ¥
E Gao
3.884 %
1,116,150 3.884 % 33 M ¥

Company contact information

Shenyang Xingqi Pharmaceutical Co., Ltd.

30/F, Building B, Enterprise Plaza 125, Qingnian Street

110016, Shenyang

+

http://www.sinqi.com
address Shenyang Xingqi Pharmaceutical Co.,Ltd.(300573)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Ratings for Shenyang Xingqi Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
259.6
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+42.38% 4.47B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+12.55% 9.06B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-12.75% 4.96B
YUHAN CORPORATION Stock Yuhan Corporation
+5.23% 3.9B
INDIVIOR PLC Stock Indivior PLC
+20.01% 2.41B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-19.05% 2.41B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-28.72% 2.23B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+11.13% 2.02B
SUPERNUS PHARMACEUTICALS, INC. Stock Supernus Pharmaceuticals, Inc.
+3.94% 1.65B
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 1.64B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300573 Stock
  4. Company Shenyang Xingqi Pharmaceutical Co.,Ltd.